BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 14686008)

  • 1. [Frequency of anemia in patients with ovarian cancer: assessment of our own data in connection with the European Cancer Anemia Survey (ECAS)].
    Lehoczky O; Pulay T
    Orv Hetil; 2003 Nov; 144(45):2225-8. PubMed ID: 14686008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anemia profiles in patients with lung cancer: what have we learned from the European Cancer Anaemia Survey (ECAS)?
    Kosmidis P; Krzakowski M;
    Lung Cancer; 2005 Dec; 50(3):401-12. PubMed ID: 16191450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of cancer-related anemia in patients with breast or gynecologic cancer: new insights based on results from the European Cancer Anemia Survey.
    Barrett-Lee P; Bokemeyer C; Gascón P; Nortier JW; Schneider M; Schrijvers D; Van Belle S;
    Oncologist; 2005 Oct; 10(9):743-57. PubMed ID: 16249356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of anemia in patients receiving neoadjuvant chemotherapy for locally advanced esophagogastric cancer.
    Voelter V; Schuhmacher C; Busch R; Peschel C; Siewert JR; Lordick F
    Ann Thorac Surg; 2004 Sep; 78(3):1037-41. PubMed ID: 15337044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Frequency of blood transfusions for anemia caused by chemotherapy in ovarian cancer patients. Thoughts about the guidelines modified in 2006 for the treatment of anemic cancer patients by the European Organisation for Research and Treatment of Cancer].
    Lehoczky O; Pulay T
    Orv Hetil; 2007 Nov; 148(45):2133-7. PubMed ID: 17984024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The occurrence of anemia in small cell lung cancer patients during first-line chemotherapy].
    Swiatoniowski G; Bruzewicz S; Bronowicz Z; Kłaniewski T
    Pol Merkur Lekarski; 2009 Feb; 26(152):98-100. PubMed ID: 19388511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment serum hemoglobin level and a preliminary investigation of intratumoral microvessel density in advanced ovarian cancer.
    Ferrero A; Zola P; Mazzola S; Fuso L; Sarotto I; Ravarino N; Spanu PG; Jacomuzzi ME; Carus AP; Sismondi P
    Gynecol Oncol; 2004 Nov; 95(2):323-9. PubMed ID: 15491752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer anemia survey in Division of Medical Oncology at Siriraj Hospital (CAS).
    Ithimakin S; Srimuninnimit V
    J Med Assoc Thai; 2009 Mar; 92 Suppl 2():S110-8. PubMed ID: 19562994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new induction schedule of epoetin alfa 40.000 IU in anemic patients with advanced lung cancer.
    Ariganello O; Mancuso A; Di Molfetta M; Diana F; Beccaglia P; Cortesi E; De Marinis F
    Lung Cancer; 2004 Oct; 46(1):119-24. PubMed ID: 15364140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged topotecan infusion with cisplatin in the first-line treatment of ovarian cancer: an NYGOG and ECOG study.
    Hochster HS; Plimack ER; Mandeli J; Wadler S; Runowicz C; Goldberg G; Speyer J; Wallach R; Muggia F;
    Gynecol Oncol; 2006 Feb; 100(2):324-9. PubMed ID: 16253316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group comparing quality of life in patients with ovarian cancer treated with cisplatin/paclitaxel versus carboplatin/paclitaxel.
    Greimel ER; Bjelic-Radisic V; Pfisterer J; Hilpert F; Daghofer F; du Bois A;
    J Clin Oncol; 2006 Feb; 24(4):579-86. PubMed ID: 16446330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of hemoglobin levels on treatment outcome in patients with nasopharyngeal carcinoma treated with sequential chemoradiotherapy or radiotherapy alone.
    Chua DT; Sham JS; Choy DT
    Cancer; 2004 Jul; 101(2):307-16. PubMed ID: 15241828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial of anemia correction with two different hemoglobin targets in the first-line chemotherapy of advanced gastric cancer.
    Park SH; Nam E; Bang SM; Cho EK; Shin DB; Lee JH
    Cancer Chemother Pharmacol; 2008 Jun; 62(1):1-9. PubMed ID: 17690882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and clinical impact of chemotherapy induced myelotoxicity in cancer patients: an observational retrospective survey.
    Repetto L;
    Crit Rev Oncol Hematol; 2009 Nov; 72(2):170-9. PubMed ID: 19406660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weekly administration of epoetin beta for chemotherapy-induced anemia in cancer patients: results of a multicenter, Phase III, randomized, double-blind, placebo-controlled study.
    Tsuboi M; Ezaki K; Tobinai K; Ohashi Y; Saijo N
    Jpn J Clin Oncol; 2009 Mar; 39(3):163-8. PubMed ID: 19164318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epoetin beta (NeoRecormon) therapy in patients with solid tumours receiving platinum and non-platinum chemotherapy: a meta-analysis.
    Boogaerts M; Oberhoff C; Ten Bokkel Huinink W; Nowrousian MR; Hayward CR; Burger HU
    Anticancer Res; 2006; 26(1B):479-84. PubMed ID: 16739308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the effectiveness of treatment with erythropoietin on anemia, cognitive functioning and functions studied by comprehensive geriatric assessment in elderly cancer patients with anemia related to cancer chemotherapy.
    Massa E; Madeddu C; Lusso MR; Gramignano G; Mantovani G
    Crit Rev Oncol Hematol; 2006 Feb; 57(2):175-82. PubMed ID: 16213740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the serum erythropoietin levels in chemotherapy-naive and cisplatin-treated cancer patients.
    Arslan M; Evrensel T; Kurt E; Demiray M; Ercan I; Kanat O; Ozkan A; Manavoglu O
    Neoplasma; 2005; 52(1):43-5. PubMed ID: 15739025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of once-weekly epoetin beta on survival in patients with metastatic breast cancer receiving anthracycline- and/or taxane-based chemotherapy: results of the Breast Cancer-Anemia and the Value of Erythropoietin (BRAVE) study.
    Aapro M; Leonard RC; Barnadas A; Marangolo M; Untch M; Malamos N; Mayordomo J; Reichert D; Pedrini JL; Ukarma L; Scherhag A; Burger HU
    J Clin Oncol; 2008 Feb; 26(4):592-8. PubMed ID: 18235117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Erythropoietic protein supportive treatment in small cell lung cancer].
    Tamási L; Müller V; Magyar P; Losonczy G
    Magy Onkol; 2008 Mar; 52(1):43-6. PubMed ID: 18403296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.